Andrea Charles | 08/17/2011
Dr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants present the most problems. Potts also shares her insights on common myths surrounding mycoplasma and why they persist, developments in PCR kits and how to ensure the safety of raw materials.
To continue reading this story Click Here
RECOMMENDED
Pharma Contract Manufacturing 2025
2025-03-03
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More